1. Underhill HR, Yuan C. Carotid MRI: a tool for monitoring individual response to cardiovascular therapy? Expert Rev Cardiovasc Ther. 2011. 9:63–80.
2. Hatsukami TS, Yuan C. MRI in the early identification and classification of high-risk atherosclerotic carotid plaques. Imaging Med. 2010. 2:63–75.
3. Yim YJ, Choe YH, Ko Y, et al. High signal intensity halo around the carotid artery on maximum intensity projection images of time-of-flight MR angiography: a new sign for intraplaque hemorrhage. J Magn Reson Imaging. 2008. 27:1341–1346.
4. Young VE, Patterson AJ, Tunnicliffe EM, et al. Signal-to-noise ratio increase in carotid atheroma MRI: a comparison of 1.5 and 3 T. Br J Radiol. 2012. 85:937–944.
5. Mihai G, Winner MW, Raman SV, Rajagopalan S, Simonetti OP, Chung YC. Assessment of carotid stenosis using three-dimensional T2-weighted dark blood imaging: initial experience. J Magn Reson Imaging. 2012. 35:449–455.
6. Costanzo P, Cleland JG, Atkin SL, Vassallo E, Perrone-Filardi P. Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Curr Treat Options Cardiovasc Med. 2012. 14:50–56.
7. Dong L, Wang J, Yarnykh VL, et al. Efficient flow suppressed MRI improves interscan reproducibility of carotid atherosclerosis plaque burden measurements. J Magn Reson Imaging. 2010. 32:452–458.
8. Yang EY, Polsani VR, Washburn MJ, et al. Real-time co-registration using novel ultrasound technology: ex vivo validation and in vivo applications. J Am Soc Echocardiogr. 2011. 24:720–728.
9. Duivenvoorden R, de Groot E, Elsen BM, et al. In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging. 2009. 2:235–242.
10. Horie N, Morikawa M, Ishizaka S, et al. Assessment of carotid plaque stability based on the dynamic enhancement pattern in plaque components with multidetector CT angiography. Stroke. 2012. 43:393–398.
11. Tartari S, Rizzati R, Righi R, et al. High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography: one-stop shopping for the comprehensive assessment of carotid atherosclerosis. AJR Am J Roentgenol. 2011. 196:1164–1171.
12. Kwee RM, van Oostenbrugge RJ, Hofstra L, et al. Identifying vulnerable carotid plaques by noninvasive imaging. Neurology. 2008. 70:2401–2409.
13. Patterson AJ, Tang TY, Graves MJ, Muller KH, Gillard JH. In vivo carotid plaque MRI using quantitative T2* measurements with ultrasmall superparamagnetic iron oxide particles: a dose-response study to statin therapy. NMR Biomed. 2011. 24:89–95.
14. Virani SS, Catellier DJ, Pompeii LA, et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011. 219:596–602.
15. Muller M, van der Graaf Y, Algra A, Hendrikse J, Mali WP, Geerlings MI. Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study. Ann Neurol. 2011. 70:237–244.
16. Ota H, Yu W, Underhill HR, et al. Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb Vasc Biol. 2009. 29:1696–1701.
17. Kurosaki Y, Yoshida K, Endo H, Chin M, Yamagata S. Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery. 2011. 68:62–67. discussion 67.
18. Albuquerque LC, Narvaes LB, Maciel AA, et al. Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis. J Vasc Surg. 2007. 46:1130–1137.
19. Virani SS, Nambi V, Hoogeveen R, et al. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011. 32:459–468.
20. Degnan AJ, Young VE, Gillard JH. Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis. Expert Rev Cardiovasc Ther. 2012. 10:37–53.
21. Saam T, Yuan C, Chu B, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007. 194:e34–e42.
22. Lee JM, Robson MD, Yu LM, et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol. 2009. 54:1787–1794.